Search Results for “H19-423_V1.0 Latest Test Testking 🍀 H19-423_V1.0 Practical Information 📄 H19-423_V1.0 Test Price 🕔 Go to website ☀ www.pdfvce.com ️☀️ open and search for ➠ H19-423_V1.0 🠰 to download for free 🎤H19-423_V1.0 Download Pdf” – Page 26

Evaluation of the Immunogenicity of the Synthetic α-Melanocyte-Stimulating Hormone (α-MSH) Analogue Afamelanotide ([Nle 4 – D -Phe 7 ]-α-MSH, Scenesse ® ) in Erythropoietic Protoporphyria Patients by ELISA Detecting Both Anti-Afamelanotide and Anti-α-MSH Antibodies

203

Lengweiler, S. , Kreim, S. , Barman-Aksozen, J., Maurer, M. and Minder, E.+: Evaluation of the immunogenicity of the α-melanocyte-stimulating hormone (α-MSH) analogue afamelanotide ([Nle 4-D-Phe 7] – α-MSH, scenesse®) in erythropoietic protoporphyria patients by ELISA detecting both anti-afamelanotide and anti-α-MSH antibodies. Skin Pharmacol. Physiol. 2015: 28; 103-113. IF: 2.48

o.203

18.	Siebenhaar, F., Weller, K., Młynek, A., Magerl, M., Altrichter, S., Vieira dos Santos, R., Maurer, M., and Zuberbier, T.: Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin. Exp. Dermatol. 2007: 32; 241-245. IF: 1.52

Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria

356

Yu, L., Buttgereit, T., Stahl Skov, P., Schmetzer, O., Scheffel, J., Kocatürk, E., Zawar, V., Magerl, M., and Maurer, M.+: Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria. J. Eur. Acad. Dermatol. Venereol. 2019: 33; 1747-1754. IF: 5.25

o.356

H1-antihistamine inhibition of histamine- and codeine-induced wheals does not predict response in chronic cold urticaria

353

Gorczyza, M., Curto-Barredo, L., Krause, K., Church, M. K., Hawro, T., Metz, M., Giménez-Arnau, A., and Maurer, M.+: H1-antihistamine inhibition of histamine and codeine-induced wheals does not predict response in chronic cold urticaria. J. Allergy Clin. Immunol. Pract. 2019: 7; 2043-2044. IF: 7.57

o.353

352	Weller, K., Church, M. K., Metz, M., Hawro, T., Ohanyan, T., Staubach, P., and Maurer, M.+: The response to treatment in chronic spontaneous urticaria depends on how it is measured. J. Allergy Clin. Immunol. Pract. 2019: 7; 2055-2056. IF: 7.57

o.352

351	*Maurer, M.+*, Raap, U., Staubach, P., Richter-Huhn, G., Bauer, A., Oppel, E. M., Hillen, U., Bäumer, D., Reinhardt, M., and Chapman-Rothe, N.: Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study. Clin. Exp. Allergy 2019: 49; 655-662. IF: 4.22

o.351

33.	Maurer, M.: Cold urticaria: a management model for difficult-to-treat chronic urticaria. Ann. Dermatol. Vener. 2009: 136; 15-18. IF: 0.39

344	Chuamanochan, M., Weller, K., Feist, E., Kallinich, T., Maurer, M., Kümmerle-Deschner, J., and Krause, K.+: State of care for patients with systemic autoinflammatory diseases – results of a tertiary care survey. World Allergy Organ. J. 2019: 12; 100019. IF: TBD (IF 2018: 3.68)

o.344

Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: results of a large cross-sectional study

128

Ngouateu, O. B., Kollo, P., Ravel, C., Derreure, J., Kamtchouing, P., Same-Ekobo, A., von Stebut, E., Maurer, M. and Dondji, B.+: Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: Results of a large cross-sectional study. T. Roy. Soc. Trop. Med. H. 2012: 106; 137-142. IF: 1.82

224	Altrichter, S., Wosny, K., and Maurer, M.+: Successful treatment of cholinergic urticaria with methantheliniumbromide. J. Dermatol. 2015: 42; 422-4249. IF: 1.57

Results